EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B

M Gordon Joyce, Amy Bao, Man Chen, Ivelin S Georgiev, Li Ou, Tatsiana Bylund, Aliaksandr Druz, Wing-Pui Kong, Dongjun Peng, Emily J Rundlet, Joseph G Van Galen, Shuishu Wang und 7 weitere

Pathogens and Immunity · 11.12.2019 · 4 (2) · 294

DOI: 10.20411/pai.v4i2.338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Immunity, online erschienen am 11.12.2019. Verfasst von M Gordon Joyce und 18 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory syncytial virus (RSV) subtypes, A and B, co-circulate in annual epidemics and alternate in dominance. We have shown that a subtype A RSV fusion (F) glycoprotein, stabilized in its prefusion conformation by DS-Cav1 mutations, is a promising RSV-vaccine immunogen, capable of boosting RSV-neutralizing titers in healthy adults. In both humans and vaccine-tested animals, neutralizing titers elicited by this subtype A DS-Cav1 immunogen were ~ 2- to 3-fold higher against the homologous subtype A virus than against the heterologous subtype B virus.

Methods

To understand the molecular basis for this subtype difference, we introduced DS-Cav1 mutations into RSV strain B18537 F, determined the trimeric crystal structure, and carried out immunogenicity studies.

Results

The B18537 DS-Cav1 F structure at 2-Å resolution afforded a precise delineation of prefusion F characteristics, including those of antigenic site Ø, a key trimer-apex site. Structural comparison with the subtype A prefusion F indicated 11% of surface residues to be different, with an alpha-carbon root-mean-square deviation (RMSD) of 1.2 Å; antigenic site Ø, however, resulted in 23% of its surface residues and had an alpha-carbon RMSD of 2.2 Å. Immunization of vaccine-tested animals with DS-Cav1-stabilized B18537 F induced neutralizing responses ~100-fold higher than with postfusion B18537 F. Notably, elicited responses neutralized RSV subtypes A and B at similar levels and were directed towards both conserved equatorial and diverse apical regions.

Conclusion

We propose that structural differences in apical and equatorial sites–coupled to differently focused immune responses–provide a molecular explanation for observed differences in elicited subtype A and B neutralizing responses.Keywords: antigenic site; crystal structure; epitope; fusion glycoprotein; immunogenicity; neutralization; RSV subtype; vaccine

Schlagwörter

Stichwörter der Autor:innen

RSV subtypeantigenic sitecrystal structureepitopefusion glycoproteinimmunogenicityneutralizationvaccine

Autor:innen und Institutionen

  • Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland.
  • Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee.
  • Department of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas.

Zitieren

APA

Joyce, M. G., Bao, A., Chen, M., Georgiev, I. S., Ou, L., Bylund, T., Druz, A., Kong, W. P., Peng, D., Rundlet, E. J., Van Galen, J. G., Wang, S., Yang, Y., Zhang, B., Chuang, G. Y., McLellan, J. S., Graham, B. S., Mascola, J. R., & Kwong, P. D. (2019). Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathogens and Immunity, 4(2), 294. https://doi.org/10.20411/pai.v4i2.338

Vancouver

Joyce MG, Bao A, Chen M, Georgiev IS, Ou L, Bylund T, et al. Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B. Pathogens and Immunity. 2019;4(2):294. doi:10.20411/pai.v4i2.338

BibTeX
@article{Joyce2019,
  author = {Joyce, M Gordon and Bao, Amy and Chen, Man and Georgiev, Ivelin S and Ou, Li and Bylund, Tatsiana and Druz, Aliaksandr and Kong, Wing-Pui and Peng, Dongjun and Rundlet, Emily J and Van Galen, Joseph G and Wang, Shuishu and Yang, Yongping and Zhang, Baoshan and Chuang, Gwo-Yu and McLellan, Jason S and Graham, Barney S and Mascola, John R and Kwong, Peter D},
  title = {Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B},
  journal = {Pathogens and Immunity},
  year = {2019},
  volume = {4},
  number = {2},
  pages = {294},
  doi = {10.20411/pai.v4i2.338}
}
Kostenlos starten →